JFS Wealth Advisors’s Corcept Therapeutics CORT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $5.36K | Hold |
73
| – | – | ﹤0.01% | 1060 |
|
2025
Q1 | $8.34K | Hold |
73
| – | – | ﹤0.01% | 935 |
|
2024
Q4 | $3.68K | Hold |
73
| – | – | ﹤0.01% | 1239 |
|
2024
Q3 | $3.38K | Buy |
73
+2
| +3% | +$93 | ﹤0.01% | 1262 |
|
2024
Q2 | $2.31K | Hold |
71
| – | – | ﹤0.01% | 1383 |
|
2024
Q1 | $1.79K | Hold |
71
| – | – | ﹤0.01% | 1486 |
|
2023
Q4 | $2.31K | Hold |
71
| – | – | ﹤0.01% | 1365 |
|
2023
Q3 | $1.94K | Buy |
71
+1
| +1% | +$27 | ﹤0.01% | 1373 |
|
2023
Q2 | $1.56K | Hold |
70
| – | – | ﹤0.01% | 1479 |
|
2023
Q1 | $1.52K | Sell |
70
-1
| -1% | -$22 | ﹤0.01% | 1462 |
|
2022
Q4 | $1.44K | Sell |
71
-19
| -21% | -$386 | ﹤0.01% | 1495 |
|
2022
Q3 | $2K | Sell |
90
-7
| -7% | -$156 | ﹤0.01% | 1296 |
|
2022
Q2 | $2K | Buy |
97
+34
| +54% | +$701 | ﹤0.01% | 1297 |
|
2022
Q1 | $1K | Buy |
63
+39
| +163% | +$619 | ﹤0.01% | 1607 |
|
2021
Q4 | $0 | Buy |
+24
| New | – | ﹤0.01% | 1739 |
|